ID: ALA4285090

Max Phase: Preclinical

Molecular Formula: C29H45N6O9P

Molecular Weight: 652.69

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@@H](Cc1cncn1CCCCCCCCc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)[C@@H](C)OP(=O)(O)O

Standard InChI:  InChI=1S/C29H45N6O9P/c1-20(44-45(41,42)43)26(27(30)38)34-29(40)25(18-36)33-28(39)24(32-21(2)37)16-23-17-31-19-35(23)15-11-6-4-3-5-8-12-22-13-9-7-10-14-22/h7,9-10,13-14,17,19-20,24-26,36H,3-6,8,11-12,15-16,18H2,1-2H3,(H2,30,38)(H,32,37)(H,33,39)(H,34,40)(H2,41,42,43)/t20-,24+,25+,26+/m1/s1

Standard InChI Key:  RLKOZTUQTILVBD-CHQQOIJLSA-N

Associated Targets(Human)

Serine/threonine-protein kinase PLK3 1916 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serine/threonine-protein kinase PLK2 1028 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serine/threonine-protein kinase PLK1 28605 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 652.69Molecular Weight (Monoisotopic): 652.2986AlogP: 0.46#Rotatable Bonds: 21
Polar Surface Area: 235.20Molecular Species: ACIDHBA: 9HBD: 7
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.35CX Basic pKa: 6.51CX LogP: -2.06CX LogD: -3.64
Aromatic Rings: 2Heavy Atoms: 45QED Weighted: 0.07Np Likeness Score: -0.03

References

1. Hymel D, Grant RA, Tsuji K, Yaffe MB, Burke TR..  (2018)  Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors.,  28  (19): [PMID:30174151] [10.1016/j.bmcl.2018.08.018]

Source